A biomarker is a molecule that can be measured in a biological sample in an objective,
systematic, and precise way, whose levels indicate whether a process is normal or …

Acute kidney injury is common in critically ill patients and portends a significant impact on
mortality, progressive chronic kidney disease, and cardiovascular disease and mortality …

Background Systemic inflammation in COVID-19 often leads to multiple organ failure,
including acute kidney injury (AKI). Renal replacement therapy (RRT) in combination with …

Introduction Sepsis is the leading cause of acute kidney injury (AKI) in critically ill patients.
The Kidney in Sepsis and Septic Shock (Kid-SSS) study evaluated the value of …

A brief comprehensive overview is provided of the elements constituting the burden of
kidney disease [chronic kidney disease (CKD) and acute kidney injury]. This publication can …

Diagnostic imaging using iodinated contrast media is an essential procedure in the clinical
setting and provides a large amount of beneficial information. However, the use of iodinated …

Renal involvement is frequent in COVID-19 (4–37%). This study evaluated the incidence
and risk factors of acute kidney injury (AKI) in hospitalized patients with COVID-19 …

Critically ill patients are frequently treated with empirical antibiotic therapy, including
vancomycin and β-lactams. Recent evidence suggests an increased risk of acute kidney …

Combined advances in haematopoietic cell transplantation (HCT) and intensive care
management have improved the survival of patients with haematological malignancies …

Rationale: Subclinical acute kidney injury (sub-AKI) refers to patients with low serum
creatinine but elevated alternative biomarkers of AKI. Its incidence and outcome in critically …